ZNF384 transcriptionally activated MGST1 to confer TMZ resistance of glioma cells by negatively regulating ferroptosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ZNF384 transcriptionally activated MGST1 to confer TMZ resistance of glioma cells by negatively regulating ferroptosis

Published:2024-06-01 Issue: Volume: Page:
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Yan Tengfeng,Hu Ping,Lv Shigang,Ye Minhua,Wu Miaojing,Fang Hua,Xiao Bing

Funder

Jiangxi Provincial Department of Science and Technology Natural Science Foundation Youth Fund Project

Jiangxi Provincial Department of Education Natural Science Foundation Youth Project

Science and Technology Plan of Jiangxi Provincial Health Commission

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00280-024-04681-5.pdf

Reference32 articles.

1. McClellan BL, Haase S, Nunez FJ, Alghamri MS, Dabaja AA, Lowenstein PR et al (2023) Impact of epigenetic reprogramming on antitumor immune responses in glioma. J Clin Invest 133

2. Yang K, Wu Z, Zhang H, Zhang N, Wu W, Wang Z et al (2022) Glioma targeted therapy: insight into future of molecular approaches. 21:39

3. Sun X, Klingbeil O, Lu B, Wu C (2023) BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network. 613:195–202

4. Qiu Q, Ding X, Chen J, Chen S, Wang J (2023) Nanobiotechnology-based treatment strategies for malignant relapsed glioma. J Control Release 358:681–705

5. Śledzińska P, Bebyn MG (2021) Prognostic and Predictive Biomarkers in Gliomas. 22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP